Paradigm Capital Recent News
UPDATE: Paradigm Capital Upgrades BlackBerry to Speculative Buy on Q4 Results
UPDATE: Paradigm Capital Raises PT on Valeant Pharmaceuticals on Company Acquisition
UPDATE: Paradigm Capital Lowers PT on IMRIS on Additions to Balance Sheet
UPDATE: Paradigm Capital Downgrades Nordion to Hold on Diminished Outlook
UPDATE: Paradigm Capital Upgrades Celestica to Buy, Raises PT
UPDATE: Paradigm Capital Downgrades Research In Motion to Hold on Service Model Changes
UPDATE: Paradigm Capital Reiterates Buy Rating, Raises PT on Celestica
UPDATE: Paradigm Capital Lowers PT to $67 on Valeant Pharmaceuticals on Raising Interest Cost
UPDATE: Paradigm Capital Downgrades Thompson Creek Metals Company to Hold
UPDATE: Paradigm Capital Reiterates Potash Corporation of Saskatchewan at Buy with $74 PT
UPDATE: Paradigm Capital Upgrades Nordion to Buy Post Sell-Off
UPDATE: Paradigm Capital Downgrades Nordion to Hold, Reiterates $11 PT
UPDATE: Paradigm Capital Downgrades CGI Group to Hold, Raises PT
UPDATE: Paradigm Capital Initiates Coverage on Merus Labs